ACR: albumin-creatinine ratio; HR: hazard ratio * Adjusted for age (continuous), heart failure, hypertension, diabetes, stroke, coronary artery bypass graft, peripheral artery disease and eGFR (continuous) † All-cause mortality, cardiovascular mortality, heart failure, recurrent MI, or ischemic stroke Table S4 . Model performance measures with the addition of albumin-to-creatinine ratio (ACR) to TRS2°P variables after excluding those who died within 14 days after hospitalized MI C statistic (95% CI) ACR: albumin-to-creatinine ratio; NRI: net reclassification index Note: All prediction statistics were based on 1-year predicted risk. Conventional risk factors were age (continuous), heart failure, hypertension, diabetes, stroke, coronary artery bypass graft, peripheral artery disease and eGFR (continuous). For individual outcomes, we restricted the analysis of categorical NRI to major individual outcomes, all-cause mortality, cardiovascular mortality, and heart failure, due to small number of events. * All-cause mortality, cardiovascular mortality, heart failure, recurrent MI, or ischemic stroke Figure S1 . Study population Figure S2 . 1-year probability of adverse outcomes by decile of 1-year risk with the addition of urine albumin-tocreatinine ratio (ACR) to conventional risk factors Figure S3 . Adjusted hazard ratios of composite outcome after index MI by linear splines of urine albumin-tocreatinine ratio (ACR) with three knots (10, 30, and 300 mg/g) in those who have ACR data Figure S4 . Adjusted hazard ratios of composite outcome after index MI by linear splines of converted urine albuminto-creatinine ratio (ACR) with three knots (10, 30, and 300 mg/g)
